See original article: Knoop et al. 23 (30): 7483.

ERRATUM

The October 20, 2005, article by Knoop et al, entitled “Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group” (J Clin Oncol 23:7483-7490, 2005) contained an error.

In Figure 3, Part C, the P value was given as “.614,” whereas it should have been “.0614.”

| Table of Contents

This Article

  1. doi: 10.1200/JCO.2006.01.901 JCO vol. 24 no. 6 1015

Classifications

  • Advertisement
  • Advertisement
  • Advertisement